ATYR
aTyr Pharma
ATYR
ATYR
41 hedge funds and large institutions have $77M invested in aTyr Pharma in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $72.8M → $77M (+$4.25M)
0.49% more ownership
Funds ownership: 65.21% → 65.7% (+0.49%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
41
Holding in Top 10
1
Calls
$218K
Puts
$161K
Top Buyers
| 1 | +$2.25M | |
| 2 | +$796K | |
| 3 | +$761K | |
| 4 |
Man Group
London,
United Kingdom
|
+$663K |
| 5 |
Two Sigma Investments
New York
|
+$637K |
Top Sellers
| 1 | -$3.67M | |
| 2 | -$1.24M | |
| 3 | -$578K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$429K |
| 5 |
JPMorgan Chase & Co
New York
|
-$163K |